Cargando…
Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing
Current HCV genotyping methods may have some limitations in detecting mixed infections. We aimed to determine the accuracy of genotyping and the detection of mixed-genotype infections using the Abbott-RealTime HCV Genotype II assay (Abbott-RT-PCR) in comparison with a Roche-Next Generation Sequencin...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592891/ https://www.ncbi.nlm.nih.gov/pubmed/31239457 http://dx.doi.org/10.1038/s41598-019-42605-z |
_version_ | 1783429938555125760 |
---|---|
author | Fernández-Caso, Belén Fernández-Caballero, Jose Ángel Chueca, Natalia Rojo, Eukene de Salazar, Adolfo García Buey, Luisa Cardeñoso, Laura García, Federico |
author_facet | Fernández-Caso, Belén Fernández-Caballero, Jose Ángel Chueca, Natalia Rojo, Eukene de Salazar, Adolfo García Buey, Luisa Cardeñoso, Laura García, Federico |
author_sort | Fernández-Caso, Belén |
collection | PubMed |
description | Current HCV genotyping methods may have some limitations in detecting mixed infections. We aimed to determine the accuracy of genotyping and the detection of mixed-genotype infections using the Abbott-RealTime HCV Genotype II assay (Abbott-RT-PCR) in comparison with a Roche-Next Generation Sequencing assay (Roche-NGS). Plasma samples collected from 139 HCV-infected patients tested with Abbott-RT-PCR, 114 with single genotype (GT) and 25 with mixed GTs were genotyped using Roche-NGS. Roche-NGS confirmed all single GTs obtained with Abbott-RT-PCR. One case of Abbott GT 4 was found as GT 1a using Roche-NGS. Genotype 5 was confirmed using Roche-NGS in 75% cases (3 out of 4 cases). Twenty-five patients were identified as having mixed HCVinfections using Abbott-RT-PCR. The concordance between Abbott-RT-PCR and Roche-NGS was 76% (19 out of 25 cases). Three mixed-GT infections identified with the Abbott assay (two (1b + 4); one (1a + 3)) were reported as pure 1b using Roche-NGS. Very divergent results were found for the other three samples. When compared to Roche-NGS, Abbott-RT-PCR has performed excellently for the determination of patients infected with single GTs. For patients that are categorized as having a mixed infection using Abbott-RT-PCR, we recommend an NGS assay as a confirmation test. |
format | Online Article Text |
id | pubmed-6592891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-65928912019-07-03 Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing Fernández-Caso, Belén Fernández-Caballero, Jose Ángel Chueca, Natalia Rojo, Eukene de Salazar, Adolfo García Buey, Luisa Cardeñoso, Laura García, Federico Sci Rep Article Current HCV genotyping methods may have some limitations in detecting mixed infections. We aimed to determine the accuracy of genotyping and the detection of mixed-genotype infections using the Abbott-RealTime HCV Genotype II assay (Abbott-RT-PCR) in comparison with a Roche-Next Generation Sequencing assay (Roche-NGS). Plasma samples collected from 139 HCV-infected patients tested with Abbott-RT-PCR, 114 with single genotype (GT) and 25 with mixed GTs were genotyped using Roche-NGS. Roche-NGS confirmed all single GTs obtained with Abbott-RT-PCR. One case of Abbott GT 4 was found as GT 1a using Roche-NGS. Genotype 5 was confirmed using Roche-NGS in 75% cases (3 out of 4 cases). Twenty-five patients were identified as having mixed HCVinfections using Abbott-RT-PCR. The concordance between Abbott-RT-PCR and Roche-NGS was 76% (19 out of 25 cases). Three mixed-GT infections identified with the Abbott assay (two (1b + 4); one (1a + 3)) were reported as pure 1b using Roche-NGS. Very divergent results were found for the other three samples. When compared to Roche-NGS, Abbott-RT-PCR has performed excellently for the determination of patients infected with single GTs. For patients that are categorized as having a mixed infection using Abbott-RT-PCR, we recommend an NGS assay as a confirmation test. Nature Publishing Group UK 2019-06-25 /pmc/articles/PMC6592891/ /pubmed/31239457 http://dx.doi.org/10.1038/s41598-019-42605-z Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Fernández-Caso, Belén Fernández-Caballero, Jose Ángel Chueca, Natalia Rojo, Eukene de Salazar, Adolfo García Buey, Luisa Cardeñoso, Laura García, Federico Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title | Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title_full | Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title_fullStr | Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title_full_unstemmed | Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title_short | Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
title_sort | infection with multiple hepatitis c virus genotypes detected using commercial tests should be confirmed using next generation sequencing |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6592891/ https://www.ncbi.nlm.nih.gov/pubmed/31239457 http://dx.doi.org/10.1038/s41598-019-42605-z |
work_keys_str_mv | AT fernandezcasobelen infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT fernandezcaballerojoseangel infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT chuecanatalia infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT rojoeukene infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT desalazaradolfo infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT garciabueyluisa infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT cardenosolaura infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing AT garciafederico infectionwithmultiplehepatitiscvirusgenotypesdetectedusingcommercialtestsshouldbeconfirmedusingnextgenerationsequencing |